Fresenius Kabi USA, LLC recalls Cisatracurium Besylate Injection, 20 mg per 10 mL (2 mg per mL), For intravenous injection, 10 mL Multiple Dose Vial,
Incorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label. The vial label and outer carton label contain the correct statement of 0.9% benzyl alcohol added as a preservative.
Recall notice
Incorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label. The vial label and outer carton label contain the correct statement of 0.9% benzyl alcohol added as a preservative.
Contact the company & request your remedy
We’re still writing up this recall
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
Source Page by GovInfoNow · govinfonow.com/recall/43014-fresenius-kabi-usa-llc-recalls-cisatracurium-besylate-injection-20-mg · Recall date April 5, 2016 · FDA enforcement record: FDA #D-0819-2016
Cite this page
“Fresenius Kabi USA, LLC recalls Cisatracurium Besylate Injection, 20 mg per 10 mL (2 mg per mL), For intravenous injection, 10 mL Multiple Dose Vial,.” GovInfoNow, recall dated April 5, 2016. https://govinfonow.com/recall/43014-fresenius-kabi-usa-llc-recalls-cisatracurium-besylate-injection-20-mg. Based on FDA recall #D-0819-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0819-2016%22&limit=1).
How to tell if you have this one
- Brand
Fresenius Kabi USA, LLC- Category
Drug
Contact Fresenius Kabi USA, LLC
We’ve drafted a message you can send Fresenius Kabi USA, LLC to request your refund or repair — edit it as you like.
Subject: Recall D-0819-2016 — Fresenius Kabi USA, LLC Fresenius Kabi USA, LLC recalls Cisatracurium Besylate Injection, 20 mg per Hello, I own a Fresenius Kabi USA, LLC recalls Cisatracurium Besylate Injection, 20 mg per 10 mL (2 mg per mL), For intravenous injection, 10 mL Multiple Dose Vial, that is covered by recall D-0819-2016 from Fresenius Kabi USA, LLC. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0819-2016 (April 5, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0819-2016 to see it in context.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.